TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/20/2024
Back to search
Official data from USPTO
THERATRAME
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
11/20/2024
Trademark type
Combined
Nice classes
42
Filing date
04/12/2021
Registration date
04/05/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/05/2022
Last transaction
11/20/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
33
Owner location
LIÈGE, BE
Examiner
HUSSAIN, TASNEEM
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "THERATRAME" above a twisted double helix comprised of many small circles. The double helix fuses and forms the upper half of a human including the torso, head, and two outstretched arms of a human, all comprised of small circles. The small circles scatter at the ends of the arms without forming hands. The human head, torso, and outstretched arms form the second letter "T" in the wording "THERATRAME".
Holders and representatives
Holders
THERATRAME S.A.
GESVAL S.A.
Representatives
Dana Dickson DANA DICKSON LAW
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and development; Consultation services in the field of scientific research; Providing information in the field of scientific research in the field of biochemistry and biotechnology; Providing information in the field of medical and scientific research in the field of pharmaceuticals and clinical trials; Providing information in the field of scientific research from an online searchable database; Scientific research for medical purposes in the field of cancerous diseases; Research in the field of medical researchbiological researchclinical research in the field of cancerous diseases; Research in the field of medical research and pharmacology; Scientific and technological servicesscientific research and analysis in the field of biologymedicinepharmaceuticals; Drug Discovery Services; Scientific and technological servicescomputer-assisted scientific analysis in the field of biologymedicinepharmaceuticals
Publications
History of USPTO decisions and trademark events.
29 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/20/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/20/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/17/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/18/2022
PUBO
PUBLISHED FOR OPPOSITION
01/18/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/29/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/13/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/02/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/01/2021
GNSL
LETTER OF SUSPENSION E-MAILED
12/01/2021
CNSL
SUSPENSION LETTER WRITTEN
12/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
12/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
12/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/01/2021
DOCK
ASSIGNED TO EXAMINER
12/01/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
06/30/2021
ALIE
ASSIGNED TO LIE
06/30/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/26/2021
NWAP
NEW APPLICATION ENTERED
04/15/2021
Continuous trademark protection
Get notified about every new filing that threatens THERATRAME or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.